Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products

Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.

1988 • 597 citations

Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.

1988 • 561 citations

Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal Subjects

1989 • 487 citations

Evidence for the Occurrence of a Fast-Acting Inhibitor for Tissue-Type Plasminogen Activator in Human Plasma

1984 • 345 citations

Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells.

1984 • 330 citations

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

1988 • 310 citations

Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo

1988 • 300 citations

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism.

1988 • 217 citations

Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer.

1987 • 216 citations

Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells

1990 • 182 citations

Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans

1989 • 165 citations

Effect of Thrombin on the Production of Plasminogen Activators and PA Inhibitor-1 by Human Foreskin Microvascular Endothelial Cells

1987 • 164 citations

Human endothelial cells contain one type of plasminogen activator

1984 • 156 citations

Regulation of the Synthesis and Secretion of Plasminogen Activators by Endothelial Cells

1988 • 96 citations

Quantitation of urokinase antigen in plasma and culture media by use of an elisa

1986 • 94 citations

A Monoclonal Antibody-Based Enzyme Immunoassay for Fibrin Degradation Products in Plasma

1988 • 90 citations

A monoclonal antibody, specific for human fibrinogen, fibrinopeptide A- containing fragments and not reacting with free fibrinopeptide A

1985 • 79 citations

New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.

1987 • 76 citations

A Quantitative Enzyme Immunoassay for Primary Fibrinogenolysis Products in Plasma

1987 • 61 citations

The Simultaneous Acute Release of Tissue-Type Plasminogen Activator and von Willebrand Factor in the Perfused Rat Hindleg Region

1990 • 46 citations

DDAVP Induces Systemic Release of Urokinase-Type Plasminogen Activator

1989 • 38 citations

Tumor necrosis factor (TNF) stimulates plasminogen activator inhibitor (PAI) production by endothelial cells and decreases blood fibrinolytic activity in the rat

1988 • 27 citations

Evaluation of new methods for the selective measurement of fibrin and fibrinogen degradation products

1989 • 20 citations

New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies

1988 • 15 citations

Appropriate Milieu for the Assay of Alpha-2-Antiplasmin Activity with Chromogenic Substrates

1985 • 8 citations

Deleted Work

1955 • 0 citations